Investors
*Scott Fletcher also holds 15,936,000 warrant instruments, which if exercised, would take his holding to 33.4% of the company’s enlarged share capital, assuming that no other warrants are exercised.
**Seritza Limited is a private company owned by a trust of which Chief Executive Officer, Hanno Pengilly, is a potential beneficiary.
*** Michael Haworth SGN's non-executive chairman holds 10,826,416 shares in his own name and 13,110,133 through a trust. He also holds 3,264,000 warrant instruments, which if exercised, would take his holding to 4.8% of the company’s enlarged share capital, assuming that no other warrants are exercised.
****Mrs & Mr Weatherhead also hold 2,307,700 warrant instruments, which if exercised, would take their holding to 3.66% of the company’s enlarged share capital, assuming that no other warrants are exercised.
Shares Information
Scott Fletcher*
173,267,036
30.59%
9.71%
54,988,520
Africa Finance Corporation
9.46%
53,580,573
Seritza Limited**
4.23%
Michael Haworth***
Mrs & Mr Weatherhead****
18,428,044
3.25%
23,936,549
Significant Shareholders
As at: 7 June 2023
566,501,146
Shares with voting rights
Shares in issue
566,501,146
Shares not in public hands
36.04%
Nominated Adviser and Broker
Liberum Capital Limited
Ropemaker Place Level 12
12 Ropemaker Street
London EC2Y 9AR
United Kingdom
Contacts
Broker
Novum Securities Limited
8-10 Grosvenor Gardens
London SW1W 0DH
United Kingdom
Registrar
Computershare Investor Services (BVI) Limited
Woodbourne Hall
PO Box 3162
Road Town Tortola
British Virgin Islands
Depositary
Computershare Investor Services plc
The Pavilions
Bridgwater Road
Bristol BS13 8AE
United Kingdom
Auditors
BDO LLP
55 Baker Street
London W1U 7EU
United Kingdom
Legal (UK)
Simmons & Simmons LLP
Citypoint
1 Ropemaker Street
London
EC2Y 9SS
United Kingdom
Legal (BVI)
Ogier
41 Lothbury
London EC2R 7HF
United Kingdom
Enviromental & Social
Impacto Av. Mártires da Machava,
968 Maputo, Mozambique
Registered Office
Coastal Building, Wickham's Cay II
PO Box 2221
Tortola
British Virgin Islands
Webcasts
Name
AIM Rule 26
Last updated: 6 March 2023
Company Information Disclosure
The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.
Business Description
Please follow this link for a description of the business. Incorporation and Operation Solgenics Limited was incorporated in the British Virgin Islands (registration number 1019077) as a BVIBC with limited liability under the BVI act. Its main country of operation is Mozambique.
The rights of shareholders may be different from the rights of shareholders in a UK incorporated company. Solgenics Limited is not subject to the City Code on Takeovers and Mergers.
Please follow this link for a copy of the current memorandum and articles of association (PDF 421 KB). Directors Please follow this link for the names of the Directors and their biographies. Corporate governance and internal controls
Please follow this link for details of the responsibilities of the Board, corporate governance committees and Solgenics' compliance with the UK Combined Code.
Securities Information
Exchanges and Platforms Solgenics ordinary shares are admitted to trading on the AIM. The Company has not applied to have any of its securities admitted on any other exchange.
Securities in Issue
Please follow this link to access the securities in issue
Securities not in Public Hands
Please follow this link to access the securities in issue
Significant Shareholders (as at 9 February 2023)
Please follow this link to access the significant shareholders
Restrictions on Transfer
There are currently no restrictions on the transfer of securities.
Documentation and Announcements
Admission Document
Please follow this link to access the AIM admission document (PDF 20.3MB).
Shareholder Circulars
Access all circulars and similar publications sent to shareholders within the past 12 months.
Regulatory Announcements
Access all notifications made it the past 12 months.
Accounts
Access all the Company's financial statements here.
Advisers
Read more about details of Solgenics’ nominated adviser and other key advisors below
News
Reports
Presentations
General Meetings
